Analysis of pre-treatment screening on 160 HIV/AIDS patients receiving highly active antiretroviral therapy ( AZT +3TC + EFV) treatment
Chen, X.-j.; Yu, K.; Zhou, F.
Zhonghua Liu Xing Bing Xue Za Zhi 29(11): 1166-1167
2008
ISSN/ISBN: 0254-6450 PMID: 19173952 Document Number: 619207
Document emailed within 1 workday
Related Documents
Podzamczer, D.; Barros, C.; Berenguer, J.; Gutiérrez, Félix.; Iribarren, Jé.Antonio.; Miró, Jé.M.; Molina, Jé.Pérez.; Podzamczer, D.; Aguirrebengoa, K.; Arribas, Jé.Ramón.; Boix, V.; Cahn, P.; Castro, A.; Caylá, J.; Cobo, J.; Corzo, J.Enrique.; de la Torre, J.; Dronda, F.; Ena, J.; Falcó, Vç.; Ferrer, E.; Labarga, P.; Locutura, J.; Mallolas, J.; Moreno, S.; Ocampo, A.; Ocaña, Ján.; Padilla, Bén.; Elías, Jús.Pérez.; Polo, R.; Portilla, Jín.; Riera, M.; Rivero, A.; Salavert, M.; Sanz, Jé. 2008: Treatment of opportunistic infections in adolescent and adult patients infected with the human immunodeficiency virus during the era of highly active antiretroviral therapy. AIDS Study Group (GESIDA) and National AIDS Plan Expert Committee Enfermedades Infecciosas y Microbiologia Clinica 26(6): 356-379Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Idiculla, J. 2011: Anthropometric changes in patients receiving highly active antiretroviral therapy (ART) Journal of the Association of Physicians of India 59: 530; Author Reply 530
Werner, M.L.F.; Pone, M.V.d.S.; Fonseca, V.ân.M.; Chaves, C.él.R.M.d.M. 2010: Lipodystrophy syndrome and cardiovascular risk factors in children and adolescents infected with HIV/AIDS receiving highly active antiretroviral therapy Jornal de Pediatria 86(1): 27-32
Werner, M.L.F.; Pone, M.V.d.S.; Fonseca, V.ân.M.; Chaves, C.él.R.M.d.M. 2010: Lipodystrophy syndrome and cardiovascular risk factors in children and adolescents infected with HIV/AIDS receiving highly active antiretroviral therapy Jornal de Pediatria 86(1): 27-32
Sevastianova, K.; Sutinen, J.; Westerbacka, J.; Ristola, M.; Yki-Järvinen, H. 2005: Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy Antiviral Therapy 10(8): 925-935
Talukdar, A.; Ghosal, M.Kumar.; Sanyal, D.; Talukdar, P.Sengupta.; Guha, P.; Guha, S.Kamal.; Basu, S. 2013: Determinants of quality of life in HIV-infected patients receiving highly active antiretroviral treatment at a medical college ART center in Kolkata, India Journal of the International Association of Providers of AIDS Care 12(4): 284-290
Sulaiman, M.M.; Shettima, J.; Ummate, I.; Arogundade, F.A.; Yusuph, H.; Nwankwo, E.; Sanusi, A.A.; Akinsola, A. 2022: Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 33(1): 72-79
Pomerantz, R.J. 1999: HIV patients receiving HAART therapy can still transmit the virus. Highly active antiretroviral chemotherapy American Family Physician 59(10): 2855
Bwana, V.; Tenu, F.; Magesa, S.M.; Mfinanga, S.G. 2011: Smear positive pulmonary tuberculosis among HIV patients receiving highly active antiretroviral therapy in Dar es Salaam, Tanzania Tanzania Journal of Health Research 13(1): 14-20
Girardi, E.; Sabin, C.A.; d'Arminio Monforte, A.; Hogg, B.; Phillips, A.N.; Gill, M.John.; Dabis, F.; Reiss, P.; Kirk, O.; Bernasconi, E.; Grabar, S.; Justice, A.; Staszewski, S.; Fätkenheuer, G.; Sterne, J.A.C. 2005: Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 41(12): 1772-1782
Da Silva, C.A.L.; Dourado, I.ês.; Dahia, S.R.; Harzheim, E.; Rutherford, G.W. 2008: Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil Journal of Public Health Dentistry 68(3): 178-181
Begovac, J.; Lisić, M.; Lukas, D.; Maretić, T.; Kniewald, T.; Novotny, T.E. 2006: Marked improvement in survival among adult Croatian AIDS patients after the introduction of highly active antiretroviral treatment Collegium Antropologicum 30(1): 175-179
Baiocchi, O.C.G.; Colleoni, G.W.B.; Navajas, E.V.; Duarte, L.Claudio.C.; Alves, A.C.; Andrade, A.Lucia.S.S.; Kerbauy, J.; Oliveira, J.Salvador.R. 2002: Impact of highly active antiretroviral therapy in the treatment of HIV-infected patients with systemic non-Hodgkin's lymphoma Acta Oncologica 41(2): 192-196
Bachur, T.Paschoalette.Rodrigues.; Vale, J.Martins.; Coêlho, I.Castelo.Branco.; Queiroz, T.Régia.Bezerra.Sales.de.; Chaves, C.de.Souza. 2008: Enteric parasitic infections in HIV/AIDS patients before and after the highly active antiretroviral therapy Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 12(2): 115-122
Bachur, T.Paschoalette.Rodrigues.; Vale, J.Martins.; Coêlho, I.Castelo.Branco.; Queiroz, T.Régia.Bezerra.Sales.de.; Chaves, C.de.Souza. 2008: Enteric parasitic infections in HIV/AIDS patients before and after the highly active antiretroviral therapy Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 12(2): 115-122
Domingos, H.; Cunha, R.V.ân.d.; Paniago, A.M.M.; Martins, D.M.; Elkhoury, E.B.ão.; Souza, A.S.d. 2009: Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 13(2): 130-136
Olawumi, H.O.; Olatunji, P.O.; Salami, A.K.; Odeigah, L.; Iseniyi, J.O. 2008: Effect of highly active antiretroviral therapy on CD4 count and weight in AIDS patients seen at the UITH, Ilorin Nigerian Journal of Clinical Practice 11(4): 312-315
Palacios, R.; Merchante, N.ás.; Macias, J.; González, M.; Castillo, J.ús.; Ruiz, J.; Márquez, M.; Gómez-Mateos, J.ús.; Pineda, J.A.; Santos, J.ús. 2006: Incidence of and risk factors for insulin resistance in treatment-naive HIV-infected patients 48 weeks after starting highly active antiretroviral therapy Antiviral Therapy 11(4): 529-535